2011 Annual Meeting | Therapy of Neuromuscular Disease

��ɫ��

2011 Annual Meeting | Therapy of Neuromuscular Disease

Date Thursday 04/14/11

Time 12:00 PM - 02:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Carlayne E. Jackson, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with current recommended treatment approaches to selected peripheral neuropathies, neuromuscular junction disorders, and motor neuron diseases based on available evidence in the literature as well as expert opinion.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Audience Participation

Event Timeline
12:00 PM - 12:40 PM		Amyotrophic Lateral Sclerosis: How to Treat the "Untreatable" Carlayne E. Jackson, MD, FAAN
12:00 PM - 02:00 PM		Break
12:40 PM - 01:20 PM		Peripheral Neuropathy: Update in Effective Therapies Patrick M. Grogan, MD, FAAN
01:20 PM - 02:00 PM		Myasthenia Gravis: Treatment Options–Issues and (Some) Answers John T. Kissel, MD, FAAN

Faculty Disclosures
Carlayne E. Jackson, MD, FAAN	Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for AAN. The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital.
Patrick M. Grogan, MD, FAAN	No disclosure on file
John T. Kissel, MD, FAAN	Dr. Kissel has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��